Literature DB >> 22908331

CD28-B7 interaction modulates short- and long-lived plasma cell function.

Modesta N Njau1, Jin Hyang Kim, Craig P Chappell, Rajesh Ravindran, Leela Thomas, Bali Pulendran, Joshy Jacob.   

Abstract

The interaction of CD28, which is constitutively expressed on T cells, with B7.1/B7.2 expressed on APCs is critical for T cell activation. CD28 is also expressed on murine and human plasma cells but its function on these cells remains unclear. There are two types of plasma cells: short-lived ones that appear in the secondary lymphoid tissue shortly after Ag exposure, and long-lived plasma cells that mainly reside in the bone marrow. We demonstrate that CD28-deficient murine short- and long-lived plasma cells produce significantly higher levels of Abs than do their wild-type counterparts. This was owing to both increased frequencies of plasma cells as well as increased Ab production per plasma cell. Plasma cells also express the ligand for CD28, B7.1, and B7.2. Surprisingly, deficiency of B7.1 and B7.2 in B cells also led to higher Ab levels, analogous to Cd28(-/-) plasma cells. Collectively, our results suggest that the CD28-B7 interaction operates as a key modulator of plasma cell function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908331      PMCID: PMC4850075          DOI: 10.4049/jimmunol.1102728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals.

Authors:  Giuliana Cassese; Sergio Arce; Anja E Hauser; Katja Lehnert; Beate Moewes; Miro Mostarac; Gwendolin Muehlinghaus; Martin Szyska; Andreas Radbruch; Rudolf A Manz
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

Review 2.  Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics.

Authors:  Kim L Good-Jacobson; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-09-15       Impact factor: 5.422

3.  Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.

Authors:  Modesta P Ndejembi; John R Teijaro; Deepa S Patke; Adam W Bingaman; Meena R Chandok; Agnes Azimzadeh; Steven G Nadler; Donna L Farber
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells.

Authors:  Hyung W Lim; Peter Hillsamer; Allison H Banham; Chang H Kim
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.

Authors:  C B Thompson; T Lindsten; J A Ledbetter; S L Kunkel; H A Young; S G Emerson; J M Leiden; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

6.  CD28 costimulation promotes the production of Th2 cytokines.

Authors:  I C Rulifson; A I Sperling; P E Fields; F W Fitch; J A Bluestone
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

7.  Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus.

Authors:  C K Wong; L C W Lit; L S Tam; E K Li; C W K Lam
Journal:  Rheumatology (Oxford)       Date:  2005-05-03       Impact factor: 7.580

8.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation.

Authors:  F Borriello; M P Sethna; S D Boyd; A N Schweitzer; E A Tivol; D Jacoby; T B Strom; E M Simpson; G J Freeman; A H Sharpe
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

9.  Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.

Authors:  M Hebbar; P Jeannin; G Magistrelli; P-Y Hatron; E Hachulla; B Devulder; J-Y Bonnefoy; Y Delneste
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

10.  Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

Authors:  T Defrance; B Vanbervliet; F Brière; I Durand; F Rousset; J Banchereau
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

View more
  15 in total

1.  CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy.

Authors:  P M Abraham; S H Quan; D Dukala; B Soliven
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche.

Authors:  Joel R Wilmore; David Allman
Journal:  J Immunol       Date:  2017-08-01       Impact factor: 5.422

3.  The Histone Demethylase LSD1 Regulates B Cell Proliferation and Plasmablast Differentiation.

Authors:  Robert R Haines; Benjamin G Barwick; Christopher D Scharer; Parimal Majumder; Troy D Randall; Jeremy M Boss
Journal:  J Immunol       Date:  2018-09-19       Impact factor: 5.422

Review 4.  Novel therapies for memory cells in autoimmune diseases.

Authors:  P Bhargava; P A Calabresi
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

5.  Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.

Authors: 
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

6.  CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif.

Authors:  Cheryl H Rozanski; Adam Utley; Louise M Carlson; Matthew R Farren; Megan Murray; Lisa M Russell; Jayakumar R Nair; ZhengYu Yang; William Brady; Lee Ann Garrett-Sinha; Stephen P Schoenberger; Jonathan M Green; Lawrence H Boise; Kelvin P Lee
Journal:  J Immunol       Date:  2015-04-01       Impact factor: 5.422

7.  Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis.

Authors:  Jason S Ellis; So-Hee Hong; Habib Zaghouani; Helen Braley-Mullen
Journal:  J Immunol       Date:  2013-10-04       Impact factor: 5.422

8.  BAFF upregulates CD28/B7 and CD40/CD154 expression and promotes mouse T and B cell interaction in vitro via BAFF receptor.

Authors:  Feng Zhang; Shan-Shan Song; Jin-Ling Shu; Ying Li; Yu-Jing Wu; Qing-Tong Wang; Jing-Yu Chen; Yan Chang; Hua-Xun Wu; Ling-Ling Zhang; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

9.  Belatacept and CD28 Costimulation Blockade: Preventingand Reducing Alloantibodies over the Long Term.

Authors:  Ronald F Parsons; Christian P Larsen; Thomas C Pearson; I Raul Badell
Journal:  Curr Transplant Rep       Date:  2019-11-02

10.  CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells.

Authors:  Monica Macal; Miguel A Tam; Charles Hesser; Jeremy Di Domizio; Psylvia Leger; Michel Gilliet; Elina I Zuniga
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.